Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v3.8.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Cash flows from operating activities:          
Net earnings (loss) $ 261 $ 169 $ 461 $ 738  
Adjustments to reconcile net earnings to net cash provided by operating activities:          
Depreciation and amortization 228 92 615 272  
Stock-based compensation 85 41 182 109  
Share of (earnings) loss of affiliates, net (155) (37) (167) (43)  
Realized and unrealized (gains) losses on financial instruments, net (18) (7) 43 33  
Noncash interest expense     9 9  
Losses (gains) on dilution of investment in affiliate     (4) 2  
Deferred income tax expense (benefit)     286 407  
Other, net     46 24  
Changes in operating assets and liabilities          
Current and other assets     5 (29)  
Payables and other current liabilities     (163) 129  
Net cash provided (used) by operating activities     1,313 1,651  
Cash flows from investing activities:          
Investments in and loans to cost and equity investees     (760) (762)  
Cash proceeds from sale of investments     20 61  
Net cash paid for the acquisition of Formula 1     (1,647)    
Capital expended for property and equipment     (407) (318)  
Purchases of short term investments and other marketable securities       (258)  
Sales of short term investments and other marketable securities       273  
Other investing activities, net     (120) (6)  
Net cash provided (used) by investing activities     (2,914) (1,010)  
Cash flows from financing activities:          
Borrowings of debt     5,820 2,019  
Repayments of debt     (4,819) (876)  
Proceeds from Issuance of Series C Liberty Formula One Common Stock     1,938    
Proceeds from Liberty Braves common stock rights offering       203  
Shares repurchased by subsidiary     (996) (1,225)  
Cash dividends paid by subsidiary     (45)    
Taxes paid in lieu of shares issued for stock-based compensation     (95) (43)  
Other financing activities, net     12 20  
Net cash provided (used) by financing activities     1,815 98  
Effect of Exchange Rate on Cash and Cash Equivalents     7    
Net increase (decrease) in cash and cash equivalents     221 739  
Cash and cash equivalents at beginning of period     562 201 $ 201
Cash and cash equivalents at end of period $ 783 $ 940 $ 783 $ 940 $ 562